Concepedia

Eric D. Soli

ED

9

Publications

352

Citations

9

H-Index

1999

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Maryland, College Park

Eric D. Soli is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in engineering, organic chemistry, and chemistry.

ORCID

Top concepts

Publications per year

1999–2014

9

Publications

9

Azide and Cyanide Displacements via Hypervalent Silicate Intermediates

Eric D. Soli, Amy S. Manoso, Michael C. Patterson et al. · The Journal of Organic Chemistry · 1999 · 132 citations

, , +15

Disposition of Vorinostat, A Novel Histone Deacetylase Inhibitor and Anticancer Agent, in Preclinical Species

Punam Sandhu, Paul A. Andrews, Maribeth P. Baker et al. · Drug Metabolism Letters · 2007 · 33 citations

, , +13

Advances in Glycosyl Azide Preparation via Hypervalent Silicates

Eric D. Soli, Philip DeShong · The Journal of Organic Chemistry · 1999 · 33 citations

, , +11

Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates

Stephanie E. Barrett, Rob S. Burke, Marc Abrams et al. · Journal of Controlled Release · 2014 · 30 citations

, , +7

Metabolism of MK-0524, a Prostaglandin D2 Receptor 1 Antagonist, in Microsomes and Hepatocytes from Preclinical Species and Humans

Brian J. Dean, Steve W. C. Chang, Maria Victoria Silva Elipe et al. · Drug Metabolism and Disposition · 2006 · 30 citations

Rows per page

1–5 of 9